BioWorld MedTech

April 7, 2011

Emerge sees a need for line of generic orthopedic devices

A new medical device company has emerged with the goal of targeting the $2 billion orthopedic trauma market with the industry's first line of high-quality generic implants and instruments. (Medical Device Daily) Read More

VisualSonics developing new photoacoustics imaging tool

International report: Volcano cleared to market PrimeWire Prestige in Japan

Shuren says start date of new harmonization body uncertain

Deals roundup: LabCorp to acquire OC shares for $85 million

MDD's food for med-tech thought

Agreements/contracts: GE partners with TomTec to 'enhance patient care'

Court Report: Hospital to pay $1.9M to settle Medicare fraud charges

Med-Tech Notes

Product Briefs

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for April 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 4, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...

Immune checkpoint inhibitors illustration of PD-1, CTLA-4 and PD-L1.

Checkpoint inhibitor journey traces Chinese firms’ path to global revenue

BioWorld

Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...